|
Market Closed -
Nasdaq
01:30:00 23/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.360 USD | +19.30% |
|
+19.30% | -41.63% |
| 13/08 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 13/08 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SPRO | Delayed | |
CBOE
| SPRO | Real-time | |
Tradegate
| 2HA | Real-time | |
Boerse Muenchen
| 2HA | Real-time | |
Deutsche Boerse AG
| 2HA | Delayed | |
Börse Stuttgart
| 2HA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.17 | 1.83 | 1.79 |
| Spread/Res. | +16.24% | -25.68% | -24.02% |
| Spread/Supp. | +22.52% | +22.52% | +20.35% |
| Support | 1.11 | 1.11 | 1.13 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SPRO Stock
- Charts Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions

















